Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approachMichaela Reiterováon March 11, 2025 at 10:00 am
Clin Chem Lab Med. 2025 Mar 13. doi: 10.1515/cclm-2024-1503. Online ahead of print. ABSTRACT OBJECTIVES: Risk-based stratification approaches using measurable residual disease (MRD) successfully help to identify T-acute lymphoblastic leukemia (T-ALL) patients at risk of relapse, whose treatment outcomes are very poor. Because of T-ALL heterogeneity and rarity, a reliable and standardized approach for flow … Read more